Finance

Beta
Lists
CURX:NASDAQ
Curanex Pharmaceuticals Inc
0,26 US$
-3,28%
(-0,0090) 1D
24 ივნ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CURX...
Open
0,27 US$
High
0,28 US$
Low
0,26 US$
Mkt. cap
7,63 მლნ.
Avg. vol.
80,77 ათ.
Volume
44,68 ათ.
52-wk high
9,18 US$
52-wk low
0,26 US$
EPS
-0,26 US$
Shares outstanding
28,36 მლნ.
No. of employees
6
Open
0,27 US$
High
0,28 US$
Low
0,26 US$
Mkt. cap
7,63 მლნ.
Avg. vol.
80,77 ათ.
Volume
44,68 ათ.
52-wk high
9,18 US$
52-wk low
0,26 US$
EPS
-0,26 US$
Shares outstanding
28,36 მლნ.
No. of employees
6
News stories
From sources across the web
About Curanex Pharmaceuticals Inc
CEO-
Employees6
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitecuranexpharma.com
Analyst
Recommendation
Action
Price Target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
677,47 ათ.
2,31 მლნ.
2,26 მლნ.
Cost of revenue
-
677,47 ათ.
2,31 მლნ.
2,26 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57,66 ათ.
273,85 ათ.
786,34 ათ.
927,20 ათ.
Operating expense
57,66 ათ.
273,85 ათ.
786,34 ათ.
927,20 ათ.
Total operating expenses
57,66 ათ.
951,33 ათ.
3,09 მლნ.
3,18 მლნ.
Operating income
-57,66 ათ.
-951,33 ათ.
-3,09 მლნ.
-3,18 მლნ.
Other non operating income
403,00
1,36 ათ.
19,52 ათ.
33,13 ათ.
EBT including unusual items
-60,35 ათ.
-954,06 ათ.
-3,07 მლნ.
-3,15 მლნ.
EBT excluding unusual items
-60,35 ათ.
-954,06 ათ.
-3,07 მლნ.
-3,15 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-60,35 ათ.
-954,06 ათ.
-3,07 მლნ.
-3,15 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-3,09 ათ.
-4,09 ათ.
-
-
Net interest expenses
-3,09 ათ.
-4,09 ათ.
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer